Abstract
AimThe aim of this study was to determine the possibility of improving erectile dysfunction using cell therapy with either human urine-derived stem cells (USCs) or USCs genetically-modified with FGF2 in a type 2 diabetic rat model.MethodsHuman USCs were collected from 3 healthy donors. USCs were transfected with FGF2 (USCs-FGF2). Sixty-five SD male rats were divided into five groups (G). A control group of normal rats (G1, n = 10), and four other test groups of type 2 diabetic erectile dysfunction rats: PBS as a negative control (G2, n = 10), USCs (G3, n = 15), lentivirus-FGF2 (G4, n = 15), and USCs-FGF2 (G5, n = 15). Diabetes was induced in the rats via a high fat diet for 28 days and a subsequent intraperitoneal injection of streptozotocin (35 mg/kg). Erectile dysfunction was screened with apomorphine (100 μg/kg). Cell injections in the test groups (G2–G5) occurred directly into the corpora cavernosa. The implanted cells were tracked at 7 days (n = 5 animals/G) and 28 days (n = 10 animals/G) post injection. Mean arterial pressure (MAP), intracavernosal pressure (ICP), expression of endothelial markers (CD31, VEGF and eNOS), smooth muscle markers (desmin and smoothelin), histological changes and erectile function were assessed for each group.ResultsUSCs expressed mesenchymal stem cell markers, and secreted a number of proangiogenic growth factors. USCs expressed endothelial cell markers (CD31 and vWF) after transfection with FGF2. Implanted USCs or USCs-FGF2 displayed a significantly raised ICP and ICP/MAP ratio (p<0.01) 28 days after intracavernous injection. Although few cell were detected within the implanted sites, histological and western blot analysis demonstrated an increased expression of endothelial and smooth muscle markers within the cavernous tissue following USC or USC-FGF2 injection.ConclusionsThe paracrine effect of USCs or USCs-FGF2 induced improvement of erectile function in type 2 diabetic rats by recruiting resident cells and increasing the endothelial expression and contents of smooth muscle.
Highlights
Erectile dysfunction (ED) is a common and distressing complication of diabetes with about 35% to 90% of diabetic men reported to suffer from ED [1]
Endothelial cell differentiation in vitro To determine the effect of fibroblast growth factor 2 (FGF2) on the endothelial differentiation of urine-derived stem cells (USCs), we identified the endothelial differentiation of USCs and USCs-FGF2 growing in USC culture medium by immuofluorescence
Stable FGF2 expression of USCs Forty-eight hours after the FGF2/GFP or GFP plasmid was transduced into USCs via lentivirus, the transduction efficiency reached .95% (Fig. 1C)
Summary
Erectile dysfunction (ED) is a common and distressing complication of diabetes with about 35% to 90% of diabetic men reported to suffer from ED [1]. ED in men with diabetes is more severe than non-diabetic ED patients [5]. The first line medication for ED, phosphodiesterase type 5 inhibitors (PDE5 inhibitors), is currently widely used in ED patient with diabetes [6,7]; the effect of PDE5 inhibitors in diabetic ED is lower than in non-diabetic ED [2]. Endothelial dysfunction and subsequent decreased smooth muscle content may be one of the pivotal reasons for this refractory response of diabetic ED. New therapeutic strategies targeted towards repairing endothelial function, in the early stage of this disorder, are needed
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.